SI-BONE(SIBN)

Focus: SI-BONE is a publicly traded medical device company focused on sacroiliac joint (SIJ) fusion solutions, with $139M in FY 2025 revenue and a specialized market position in musculoskeletal care.

Musculoskeletal

Profile data last refreshed 2h ago · AI intelligence enriched 2mo ago

Funding Stage

PUBLIC

Open Jobs

About SI-BONE

AI assessmentNot Hiring

No open roles listed right now. Follow SI-BONE to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

4/9 — Basic

Company HealthSolid

Pipeline

Early-stage

16 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Revenue

$139M

Key Products

iFuse Implant System

Sacroiliac Joint Pain / Degenerative Sacroiliitis

Growth

Flagship product driving $139M in FY 2025 revenue with multiple clinical variants (iFuse-3D, TORQ) in post-market studies.

iFuse Bedrock Granite Implant System

Spinal Fusion / Sacroiliitis

Help build intelligence for SI-BONE

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Focused product portfolio in high-unmet-need sacroiliac joint pain market with proven commercial traction ($139M FY 2025 revenue, +31% YoY growth)
Medical device innovator with multiple iFuse system variants in clinical development targeting SIJ dysfunction, joint disruption, and complex spinal deformity
Public company with stable cash position ($35M) and path to profitability, offering equity upside and career progression in specialized orthopedic space

Watch Out For

Unprofitable despite revenue growth—net loss of $43.3M in FY 2025 raises sustainability concerns if growth stalls or market adoption slows
Minimal active hiring (0 open roles at snapshot) and no disclosed headcount make entry challenging; company scale and team expansion plans unclear
Narrow therapeutic focus entirely on SIJ fusion creates career risk if competitive pressure or reimbursement challenges emerge in this single indication

Generated by Claude from SI-BONE's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Next-generation variant expanding iFuse platform into complex adult spinal deformity and revision surgery indications.

Pipeline & Clinical Trials

iFuse Implant System

Sacroiliac Joint Pain

N/A

Clinical Trials (1)

NCT01741025iFuse Implant System® Minimally Invasive Arthrodesis

N/A

SIJ fusion with iFuse-3D

Sacroiliac Dysfunction

N/A

Clinical Trials (1)

NCT03122899Study of Bone Growth in the Sacroiliac Joint After Minimally Invasive Surgery With Titanium Implants

N/A

Health questionnaires

Sacroiliac Joint Dysfunction

N/A

Clinical Trials (1)

NCT06706908Innovative Spinopelvic Solutions With Real-World Evidence

N/A

Index or spine revision surgery for complex adult spinal deformity

Adult Spinal Deformity

N/A

iFuse-3D implant

Pelvic Fracture

N/A

Clinical Trials (1)

NCT05367505Titanium Fusion Implant in Combination With Trans-iliac Screws for Insufficiency Fractures of the Pelvis

N/A

Surgical Intervention

Fracture;Pelvis

N/A

Clinical Trials (1)

NCT05426356Sacral Fracture Fusion/Fixation for Rapid Rehabilitation

N/A

Sacroiliac Joint Fusion With iFuse Implant System (SIFI)

Degenerative Sacroiliitis

N/A

Clinical Trials (1)

NCT01640353Sacroiliac Joint Fusion With iFuse Implant System (SIFI)

N/A

iFuse Implant System

Degenerative Sacroiliitis

N/A

Clinical Trials (1)

NCT01681004Investigation of Sacroiliac Fusion Treatment (INSITE)

N/A

iFuse Bedrock Granite Implant System

Spinal Fusion

N/A

Clinical Trials (1)

NCT05640908Pelvic Fixation and Fusion During Multilevel Spinal Surgery

N/A

iFuse Bedrock technique

Sacroiliitis

N/A

Clinical Trials (1)

NCT05276024Evaluation of the IFuse Bedrock Technique in Association with Posterior Lumbosacral Fusion with Iliac Fixation.

N/A

iFuse 3-D in Bedrock Configuration

Sacroiliac Joint Disruption

N/A

Clinical Trials (1)

NCT04062630SI Joint Stabilization in Long Fusion to the Pelvis

N/A

Pelvic CT at 5 years post-op

Degenerative Sacroilitis

N/A

Clinical Trials (1)

NCT02270203LOIS: Long-Term Follow-Up in INSITE/SIFI

N/A

iFuse TORQ TNT Implant System

Fracture; Pelvic

N/A

Clinical Trials (1)

NCT07530497Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures

N/A

iFuse INTRA Ti Implant System

Sacro Iliac Joint Pain

N/A

Clinical Trials (1)

NCT07565545Posterior-Inferior Intra-articular Cortical Piercing Titanium Implant for Sacroiliac Joint Fusion: Evaluation of Safety and Effectiveness Outcomes

N/A

0.75% bupivacaine

SI Joint Pain

PHASE_4

Clinical Trials (1)

NCT01874236Validity and Reliability of Diagnostic Findings of SI Joint Blocking

Phase 4

Use of iFuse TORQ

Sacroiliac Joint Dysfunction

PHASE_4

Clinical Trials (1)

NCT05870488iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction

Phase 4

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 2009

Portfolio: 15 clinical trials

Publications: 25 in PubMed

SEC Filings: 2 available

Financials (FY2025)

Revenue

$139M31%

R&D Spend

$15M(11%)10%

Net Income

-$43M

Research Publications(10)

Recent peer-reviewed publications with author affiliations at this company

Minimally invasive sacroiliac joint fusion: Primary endpoint results from the prospective, multicenter STACI study.

PM & R : the journal of injury, function, and rehabilitation

2026

PMID:41612848

Differential Diagnosis of Posterior Buttock Pain: A Conceptual Review Based on Topographic Localization of Pain, Is It Really the Sacroiliac Joint?

International journal of spine surgery

2025

PMID:41253507

Showing 5 of 10 publications

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

SI-BONE(SIBN)

About SI-BONE

Why Work Here

Key Products

Watch Out For

Pipeline & Clinical Trials

Recent News · SI-BONE(10)

Open Jobs (0)

Financials (FY2025)

Research Publications(10)